An increase in fat mass associated with obesity results from recruitment and differentiation of adipocyte progenitor cells. The precise origin of these cells is unknown, although accumulating evidence suggests that circulating stem cells can differentiate into cells of mesenchymal lineage. It is currently unclear whether a progenitor adipocyte population exists in circulation. One potential candidate is the fibrocyte, which may represent a common progenitor cell for several mesenchymal lineages. We demonstrate that these circulating progenitors become adipocytes when cultured under adipogenic conditions, with intracellular lipids accumulation and upregulation of proteins specific for adipocyte differentiation, including leptin, PPARγ, and FABP4. cDNA microarray analysis revealed gene clusters that were differentially regulated during adipogenesis of fibrocytes, which were similar to visceral and subcutaneous adipose tissue preadipocyte-to-adipocyte differentiation. Moreover, these progenitors engrafted and formed human adipose tissue following injection into SCID mice. Although fibrocytes express an array of chemokine receptors, we observed an up-regulation of CCR2 expression following fibrocytes differentiation into adipocytes, which was associated with increased chemotactic response to CCL2. This paradigm supports the notion that elevated CCL2 levels in visceral adipose tissue associated with Metabolic Syndrome is a chemotactic niche, whereby fibrocytes can home to and differentiate into adipocytes to perpetuate its tissue formation.
Previous studies have shown that a number of progenitor cell populations possess plasticity to differentiate into adipocytes (1) (2) (3) . Resident tissue preadipocytes, as well as stem cells derived from adipose tissue stromal vascular population can differentiate into adipocytes following adipogenic induction (4) . Similarly, bone marrow-derived mesenchymal stem cells (MSCs) can also differentiate into a number of mesodermal lineage cells, including chondrocytes (1), osteoblasts (1) , and adipocytes (1, 5) . It is well established that lineage commitment and differentiation of a progenitor or stem cell into defined phenotype requires stringent regulation of genes responsive to specific environmental cues. For adipogenesis, a number of growth factors and mitogens can initiate activation of CCAAT enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone receptors. Temporal expression pattern of these transcription factors ultimately leads to activation of adipocyte-specific genes.
Recent studies have demonstrated the existence of populations of "circulating" stem cells, which can differentiate into endothelial (6) , muscle (7) , neural (8) , or hepatic cells (9) . These cells are believed to reside primarily in the bone marrow and enter the pool of circulating blood cells when exposed to specific environmental cues. They may contribute to the maintenance of peripheral organs under homeostatic conditions or participate in tissue repair after injury. Very little is known about whether a progenitor cell population exists in circulation that can become a tissue adipocyte.
One attractive candidate is the fibrocyte. Fibrocytes are a distinct population of circulating fibroblast-like cells in peripheral blood with unique cell surface phenotype, including expression of CD45RO, CXCR4, and collagen I (10) . These cells also express CD11b, CD34, and α-smooth muscle. However, they are distinct from fibroblast, monocyte/macrophages, T and B lymphocytes, dendritic cells or their precursors, as well as epithelial and endothelial cells (11, 12) . Known functions of fibrocytes have been demonstrated to include potent stimulators of T cells in antigen-specific immunity (13) , wound healing following injury (10) , as well as pathologic fibrosis in response to local inflammation (14) .
Because these circulating cells possess morphologic and distinct phenotypic properties similar to bone marrow-derived stem cells, we hypothesized that they may be a source of circulating progenitor cells with ability to differentiate along mesodermal lineage. Specifically, we demonstrated that these cells can differentiate into adipocytes, with lipid accumulation and expression of adipocyte-specific genes. We characterized the microenvironmental conditions, including growth surface, cytokines, and cell density, which lead to the activation of signal pathways important for fibrocyte-to-adipocyte differentiation. More importantly, we demonstrated that these cells, when injected into SCID mice, can engraft in vivo and form human adipose tissue. Furthermore, we found an increase in cell surface expression of CCR2 after differentiation of fibrocytes into adipocytes, with increased chemotactic activity in response to monocyte chemoattractant protein-1 (MCP-1; CCL2). The findings support the notion that the elevated CCL2 levels within visceral adipose tissue (15) may provide the chemotactic signal to target circulating fibrocytes to the adipose tissue niche and contribute to the pathogenesis of Metabolic Syndrome.
MATERIALS AND METHODS

Fibrocytes isolation
Fibrocytes were harvested from peripheral blood mononuclear cells (PBMCs), according to previously published methods (14, 16) . Briefly, PBMCs were isolated from human leukopheresis packs by gradient centrifugation over Ficoll/Paque (Amersham Biosciences, Piscataway, NJ). After culturing on fibronectin-coated flasks for 72 h in DMEM with 20% FBS and 4% Lglutamine, nonadherent cells were removed. The adherent cells were supplemented with new media and remained incubated for 7-10 days. The cells were then gently detached from flasks by incubation with Accutase (Innovative Cell Technologies, San Diego, CA) for 10 min at 37°C. This crude fibrocyte preparation was purified of contaminating monocytes/macrophages, T cells, and B cells by magnetic immunodepletion using anti-CD14; pan-T, anti-CD2; and pan-B, anti-CD19 Dynabeads, respectively (Dynal Inc., Brown Deer, WI).
Adipogenic differentiation
Enriched fibrocytes were treated with three cycles of 3 days of adipogenic induction medium (AIM -4.5 g/l glucose, 5% FBS, 1.0 μM dexamethasone, 2.0 mM indomethacin, 1.7 μM insulin, 0.5 mM 3-isobutyl-1-methylxanthine, penicillin, streptomycin, and ±TGF-β1) followed by 3 days of adipogenic maintenance medium (AMM -4.5 g/l glucose, 5% FBS, 1.7 μM insulin, penicillin, and streptomycin). After the final AIM-AMM cycle, differentiated cells were kept in AMM for up to 28 days. All reagents with the exception of TGF-β1 (R&D Systems, Minneapolis, MN) were purchased from Sigma (St. Louis, MO).
Oil Red O staining
Cells were stained with Oil Red O to assess for lipid accumulation, as described previously (17) . Briefly, cells are washed with 1X PBS, fixed in 10% formalin solution for 1 h at room temperature, rinsed twice with PBS, followed by wash with 60% isopropanol for 5 min. Cells are then stained with Oil Red O solution for 90 min, followed by a gentle rinse with water. Cells are counterstained with hematoxylin for 3 min and washed with water before microscopic visualization. Lipid containing cells in 10 random areas of 1 mm 2 are enumerated. Four culture wells per specimen group were used to determine mean value ± SD.
Gene array analysis
Gene microarrays using Affymetrix U133 + chip (Affymetrix; Santa Clara, CA) were processed by Microarray Core Facility at UCLA (Los Angeles, CA). Samples from six different cell types were analyzed, including undifferentiated and differentiated 1) fibrocytes, 2) human subcutaneous preadipocytes (Cambrex, East Rutherford, NJ), and 3) human visceral preadipocytes (Cambrex, East Rutherford, NJ). Briefly, total mRNA was isolated using TriZol (detailed above). For first-strand cDNA synthesis, starting with 5 μg total mRNA, samples were hybridized with oligo (dT) primer for 15 min, followed by reverse transcription to synthesize second-strand cDNA (First-strand cDNA synthesis 75 min, second-strand cDNA synthesis 150 min). The ds-cDNA was purified using a PCR purification kit. This was followed by amplification and biotin labeling of anti-sense cDNA (16 hr). After cDNA fragmentation for oligonucleotide, they were hybridized with microarray for 16 hr, with subsequent washing/staining with streptavidin-PE, followed by treatment with biotinylated anti-streptavidin antibody for 90 min before they are scanned. Cluster analysis based on gene ontology and functional pathways were performed using DNA-Chip Analyzer software (www.dchip.org, Wong Lab, Harvard Medical School, Boston, MA) and PATHWAYASSIST software (Ariadne Genomics, Rockville, MD). Comparative pathway analysis was performed using PATHWAYASSIST software.
Real-time RT-PCR
Total RNA was prepared using TriZol (Invitrogen, Carlsbad, CA) as described previously (14) . For RT-PCR analysis, 2.0 μg of RNA was converted to cDNA using random hexamer primers and reverse transcriptase from Maloney murine leukemia virus. Real-time PCR was performed using ABI Prism 7700 sequence detector and SDS analysis software (PE Applied Biosystems, Foster City, CA). The following specific oligonucleotide primers are used in experiments: PPARγ -Forward (5′-
Immunocytochemistry
Fibrocyte-derived adipocyte cell monolayers were fixed in 4% paraformaldehyde for 2 h and then stained for adipocyte-specific leptin, PPARγ and FABP4 antibodies using the Vectastain ABC system (Vector Laboratories, Burlingame, CA). Briefly, cells were incubated with a 1:1 mixture of 3% hydrogen peroxide in methanol. Nonspecific binding sites were blocked with PowerBlock (Biogenex, San Ramon, CA) for 30 min, washed and overlaid with either control or species-specific anti-human antibody. Slides were then rinsed and overlaid with secondary biotinylated goat anti-rabbit IgG and incubated for 30 min. After washing twice with PBS, slides were overlaid with Vectastain ABC systems peroxidase-conjugated streptavidin and incubated for 30 min. DAB (3,3′-diaminobenzidine tetrahydrochloride) reagent was used for chromogenic localization of antibody. After optimal color development, sections were immersed in sterile water, counterstained with Mayer's hematoxylin, neutralized in 10% ammonia, and coverslipped with Permount solution after drying overnight.
Immunoblot analysis
Immunoblotting was performed based on 50 μg of protein from cellular nuclear/cytoplasmic fractions, as described previously (14) . In brief, cell monolayers in flasks were washed with HBSS and then treated with lysis buffer, after which lysates were heated at 100°C for 10 min and clarified by centrifugation. Equal amounts of protein (50 μg) were then loaded onto 10% gradient gels (Amersham Biosciences, Uppsala, Sweden) and electrophoresed at 100V until the dye-front reached the end of the gel. The gels were transferred to nitrocellulose membrane using manufacturer's suggested protocol. The membranes are blocked using 5% (w/v) evaporated milk in Tris-buffered saline containing 0.001% (v/v) Tween 20. The membranes were probed with
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primary antibody overnight using antibodies against leptin, PPARγ, and FABP4. Appropriate HRP-conjugated secondary antibodies were used based on species-specific requirement; final chemiluminescence detection is based on ECL+ Kit (Amersham Biosciences, Uppsala, Sweden) per the manufacturer's protocol.
FACS analysis
FACScan analysis was performed using samples containing a minimum of 25,000 cells as described previously (14) . Briefly, for detection of surface antigens, cells were suspended in primary antibody (diluted in PBS), incubated for 20 min on ice, followed by resuspension and washing twice. Cells were then treated with either FITC or PE conjugated secondary antibody on ice for 20 min in the dark. For intracellular staining, cells were first permeabilized using Cytofix/Cytoperm (BD-PharMingen; San Diego, CA) before addition of primary antibody with rabbit anti-human collagen I (Chemicon, Temecula, CA). Subsequent treatment with secondary PE-conjugated goat anti-rabbit Ig (Molecular Probes, Eugene, OR) was then used. For matching controls, direct-conjugated isotypes were analyzed with appropriate specific antibodies.
In vivo human adipose tissue formation
One hundred thousand fibrocyte-derived adipocytes were mixed with Matrigel (10 mg/ml, 0.1 ml volume; BD PharMingen, Bedford, MA), supplemented with 1 ng/ml bFGF and injected subcutaneously into the flanks of 4-to 6-week-old female CB17-SCID beige mice (UCLA Core Facility). The animals were kept in sterile laminar flow rooms, fed normal chow and water ad libitum, and killed 4 wk after injection. Animals were evaluated for the evidence of vascular ingrowth and formation of adipose tissue at the implanted site. Specimens were harvested from the injection site and contralateral side as controls. All skin flaps were fixed, paraffin-embedded, and sectioned, followed by staining with either hematoxylin and eosin or immunostaining with human specific leptin antibody (BD PharMingen). Microphotographs were taken to histologically evaluate the formation of human adipose tissue.
Fibrocyte chemotaxis
Chemotaxis was performed using fibronectin-coated filters (5 μm pore), as described previously (14) . In brief, confluent cells were serum-starved for 24 h, detached using Accutase, and resuspended in serum-free medium containing 0.25% HSA. For the chemotaxis assay, we used modified Boyden chambers with 5-µm pore filters coated with fibronectin. For checkerboard analysis, different concentrations of CCL2 were added to the lower chamber, and cell counts were assessed in five randomly chosen high-power fields.
Statistical analysis
Differences between groups were compared using either the Mann-Whitney U test if the data were not normally distributed, or the Student's t-test if the observations were consistent with a sample from a normally distributed population. Data were analyzed on IBM PC computer using GraphPad Prism 4 version 4.00 for Windows (GraphPad Software, San Diego, CA). Results were determined to be statistically significant if P < 0.05 unless otherwise specified.
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RESULTS
Fibrocytes are circulating progenitors that can differentiate into adipocytes and express adipocyte-specific markers
Fibrocytes comprise a small fraction of cells in the total PBMC pool (~0.5-1%) (10) . To address the potential role of fibrocytes in adipogenesis, we initially cultured PBMCs and subsequently enriched for the fibrocyte population by immunodepletion of contaminating T-cells, B-cells, and monocytes/macrophages. This population expressed a distinct combination of markers, including CXCR4, collagen I, and CD45RO by FACS analysis, in keeping with previous observations (10, 14) . Greater than 90% of cells triple-stained for all three markers (Fig. 1A) and showed homogeneous spindle-shaped morphology (Fig. 1B) . The purified fibrocytes also expressed CD34; however, similar to CD45RO, this cell marker was lost after 28 days in culture. The monocyte and macrophage markers CD14 and CD68 were not expressed.
Without specific treatments, fibrocytes retained their spindle-shaped morphology even after 28 days in culture; no spontaneous differentiation was observed. For our experiments, the enriched fibrocytes were cultured in the presence of media supplemented with growth factors known to be important for adipogenesis (1, 18, 19) . After three adipogenic induction cycles, fibrocytes transformed into cells of rounder shape, with associated intracellular lipid accumulation and positive staining for Oil Red O (Fig. 1B) . After 21 days, 50% of fibrocytes had undergone differentiation into adipogenic phenotype. This was confirmed by expression of specific genes and proteins previous known to be important during adipocyte differentiation, including fatty acid binding protein-4 (FABP4) and peroxisome proliferator-activating receptor-γ (PPARγ). Differential expression of these lineage-specific markers was evaluated for adipocytes derived from fibrocytes and compared with adipocytes derived from human subcutaneous (SQ) preadipocytes after similar treatment. Real-time quantitative RT-PCR transcript levels of FABP4 and PPARγ were increased 15-and threefold after fibrocyte adipogenesis ( Fig. 2A) , as compared with respective 78-and fivefold inductions after SQ preadipocyte-to-adipocyte differentiation (Fig. 2B) .
We also performed protein expression studies after adipogenic treatment, including immunocytostaining and immunoblot analysis. Immunocytostaining of fibrocyte-derived adipocytes resulted in strong expression of FABP4, PPARγ, and leptin, another adipose protein preferentially expressed in mature adipocytes (Fig. 2C ). Immunoblot analysis also revealed similar up-regulation of both FABP4 and PPARγ expression following differentiation of both fibrocytes and SQ preadipocytes to adipocytes (Fig. 2D) . Untreated fibrocytes did not express these proteins even after 28 days in culture (data not shown).
Fibrocyte to adipocyte differentiation is influenced by the cellular microenvironment and presence of TGF-β
We next examined whether lineage commitment and differentiation of fibrocytes to adipocytes is contingent upon specific signals influenced by the microenvironment. We found that extracellular matrix (ECM) and cell density were important determinants. Indeed, fibrocyte adipogenesis was markedly attenuated in the presence of fibronectin ECM in comparison with either collagen I or plastic ECM (Fig. 3A) . Moreover, few fibrocytes underwent adipogenic differentiation when seeded at a density of 1000 or 5000 cells/cm 2 ( Fig. 3B) . At 25,000 cells/cm 2 , there was a dramatic increase in number of fibrocytes that had differentiated to adipocytes. Others have previously demonstrated that fibrogenic cytokine TGF-β1 induces differentiation of these progenitors to α-smooth-muscle actin-positive myofibroblasts (12, 14, 20) . On this basis, we also assessed whether TGF-β1 influenced fibrocyte adipogenesis. TGF-β1 was added to newly enriched fibrocytes for 24 h before adipogenic induction and was also supplemented in the adipogenic induction media. At concentrations of 1 ng/ml and 10 ng/ml, TGF-β1 markedly reduced differentiation of fibrocytes to adipocytes (Fig. 3C) . In addition, TGF-β1 inhibited expression of PPARγ in fibrocytes and SQ-preadipocytes during adipogenic induction (Fig. 3D) . Thus, these results indicate that while TGF-β1 promotes myofibroblast differentiation, it inhibits fibrocyte-to-adipocyte differentiation.
Gene microarray analysis confirms fibrocyte to adipocyte differentiation
To better understand the epigenetic reprogramming related to fibrocyte-to-adipocyte differentiation, we performed a cDNA microarray to assess gene expression. We compared gene profile of fibrocytes, visceral preadipocytes, and SQ preadipocytes before and after differentiation to adipocytes. To validate our microarray data, we used expression data of FABP4 and PPARγ as surrogate markers for comparison between microarray and corresponding quantitative RT-PCR results. Following fibrocyte adipogenesis, FABP4 expression increased 12.8-and 15.1-fold by microarray and RT-PCR analyses, respectively, while PPARγ expression comparatively increased by 5.8-and 3.2-fold using the two methods (Fig. 4A) . Thus, the expression trends between the two techniques were mainly consistent and within a twofold variance. Of note, many of previously known mature adipocyte markers were also enriched in the fibrocyte-derived adipocyte population. Consistent with 3T3-L1 adipogenesis, up-regulation of certain secreted cytokines (i.e., CCL2), transcription factors (i.e., C/EBPα), and intracellular proteins (i.e., resistin) were seen following fibrocyte adipogenesis (Fig. 4B) .
We next evaluated expressed transcripts that were differentially regulated before and after adipogenic differentiation of fibrocytes, as well as visceral and SQ preadipocytes. Multiple transcript clusters based on either gene ontology or functional pathways were found to be involved in the differentiation process (Fig. 4C) . There was significant overlap between gene clusters enriched during fibrocyte adipogenesis and those during visceral and subcutaneous preadipocyte-to-adipocyte differentiation. For instance, genes involved in lipoprotein metabolism and fatty acid biosynthesis were globally augmented after differentiation of fibrocyte-derived adipocytes and subcutaneous and visceral preadipocyte-derived adipocytes. Conversely, other genes were differentially regulated only during fibrocyte adipogenesis, such as those involved in cell motility, chemotaxis, or metalloproteinase activity, while others are shared by two cell types, such as activation of inflammatory response genes following only fibrocyte and visceral preadipocyte differentiation to adipocytes (Fig. 4C) .
We next assessed associations between important regulatory genes that have previously been shown to be up-regulated following adipogenesis. We used PATHWAYASSIST software based on proprietary ResNet to create a sample pathway network based on expression results obtained from microarray samples (Fig. 4D ). For each cell type, differences in color intensity seen for each gene in the pathway was generated based on degree of expression change before and after adipogenic differentiation. The darker color represents a higher fold of gene induction. Pattern
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and intensity of gene expression during fibrocyte adipogenesis were compared with those from visceral and subcutaneous preadipocyte-to-adipocyte differentiation. Although changes in color intensity varied between cell types, the general expression trends, including those of related genes such C/EBPα and ADRβ3, were similar and in line with our other reported findings.
Adipocytes differentiated from fibrocytes form human adipose tissue in SCID mice
It was necessary to determine whether fibrocyte-derived adipocytes could form human adipose tissue in vivo. We used a SCID mouse chimeric model, whereby human fibrocyte-derived adipocytes embedded in Matrigel was injected subcutaneously into SCID mice. After 4 wk, we observed formation of human adipose tissue at the site of pellet implantation with associated neovascularization (Fig. 5C, D) . To characterize whether the adipose tissue was human or mouse, tissue immunohistochemistry was performed. Through staining using human-specific leptin antibody, we determined that the new adipose tissue was indeed derived from human adipocytes and not from maturation of surrounding endogenous preadipocytes (Fig. 5D) . Furthermore, staining was not observed using control antibodies or when mouse adipocytes obtained from a noninjection site was stained with the human-specific leptin antibody (Fig. 5B,  C) . These results indicate that, under a favorable microenvironment, fibrocyte-derived adipocytes can integrate themselves into tissue to form adipose tissue in vivo.
CCR2 is expressed following fibrocyte to adipocyte differentiation and is associated with increased chemotaxis in response to CCL2
Lastly, on the basis of our previous cluster analysis derived from microarray data, genes involved in chemotaxis were uniquely found to be activated during differentiation of fibrocytes to adipocytes. Specifically, expression of CCR2, the receptor for CCL2, was found to be markedly up-regulated in association with fibrocyte to adipocyte differentiation. Flow cytometric analysis demonstrated the surface protein expression of CCR2 to be augmented following fibrocyte adipogenesis (Fig. 6A) . The augmented expression was significant after 3 days and reached maximal level after 1 wk, with no additional change after 3 wk of adipogenic differentiation (Fig. 6A) . Without specific treatment, undifferentiated fibrocytes did not express CCR2. Coaddition of PPARγ antagonist GW9662 significantly attenuated this response (Fig. 6A) . We also examined the effect of adipogenic treatment on CCR2 transcript level using quantitative RT-PCR. Significant up-regulation of CCR2 expression was detected within 8 h after initiation of adipogenic induction, and at 24 h, maximal CCR2 transcript level was achieved, which was 7.3 times higher compared with untreated cells (Fig. 6B) . Elevated levels of CCR2 mRNA expression were still detected 1 and 3 wk after adipogenic treatment.
Finally, to determine whether the expression of CCR2 on cell surface was functional, chemotaxis was performed to assess for specific migration in response to CCL2. In untreated fibrocytes, little spontaneous migration was observed. When fibrocytes were treated with adipogenic media for 1 week, migratory response CCL2 was seen (Fig. 6C) . CCL2 continued to induce significant chemotaxis at week 3, associated with continual increased surface expression of CCR2.
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DISCUSSION
The current study demonstrated that fibrocytes are a circulating population of progenitor cells that can give rise to adipocytes in the presence of specific environmental cues. Most work to date on adult stem cells has focused on populations of cells from bone marrow, such as mesenchymal stem cells (MSC) (1, 19) or multipotent adult progenitor cells (MAPC) (3), a rare population that copurifies with MSC. Others have also reported stem cells within the adipose tissue with ability to differentiate into cells of mesodermal lineage (4, 21) . Although these resident cells express cell surface markers characteristic of MSC, their precise origin is unknown. Despite recent excitement and accumulating evidence for circulating progenitor cells, such as those committed to smooth muscle (7), neural (8), endothelial (6) , and hepatic lineage (9) , none have demonstrated ability to commit toward adipogenic lineage. We provide for the first time several lines of evidence that the fibrocyte is a unique adult progenitor cell in circulation that can differentiate into an adipocyte and integrate itself to form adipose tissue in vivo.
Differentiation of fibrocytes to adipocytes was induced by insulin, indomethacin, dexamethasone, and 3-isobutyl-1-methylxanthine, a combination known to stimulate the adipogenesis of bone marrow-derived stem cells. In our experiments, we saw significant upregulation of specific adipose genes and proteins after treatment, including FABP4, leptin, and PPARγ. The attenuated response in fibrocyte differentiation into adipocytes (~50%), when compared with SQ preadipocytes might be explained by heterogeneity of fibrocyte population after adipogenesis. We also acknowledge that it is possible that the repetitive adipogenic inductions used may have selected out an adipose precursor population. Because fibrocytes have been demonstrated to possess multiple lineage plasticity-unlike the already committed SQ preadipocytes-as such, these progenitor cells may require a higher degree of fastidious alterations in the epigenetic "reprogramming" of promoter responsiveness after the repetitive adipogenic induction signals (22, 23) .
Because the regulation of the adipocyte precursor is an important factor in development of obesity and diabetes, we believe it would be important to understand the permissive culture conditions required for fibrocyte lineage commitment and differentiation. The growth environments required for adipogenesis of 3T3-L1 cells and human bone marrow-derived MSC have previously been described (1, 19) . We showed here that both ECM substrata, as well as cell density, are important determinants for lineage commitment and/or adipogenic differentiation of fibrocytes. Fibronectin as an ECM was found to inhibit adipogenesis, as compared with fibrocytes plated on plastic or collagen I. Our results are not surprising and are in keeping with previous studies that showed that different ECM can influence the efficacy of adipogenesis, dependent on the cell type (24) (25) (26) . Although the precise mechanism is unknown, we speculate that fibronectin differentially regulates attachment of fibrocytes and cell cycle progression, and may even serve as a local reservoir for growth factors such as TGF-β that could inhibit adipogenesis. Moreover, as reported by others (27) (28) (29) , we also demonstrated that cell density can dictate cell morphology, which serves as a cue in lineage commitment. For fibrocytes, a high-plating density may have promoted efficient differentiation to adipocytes by facilitating necessary direct cell-cell communication or paracrine signaling by secreted cytokines.
TGFβ was found to inhibit fibrocyte adipogenesis. Others have reported the ability of TGFβ to inhibit adipogenic differentiation in preadipocytes (30) , NIH3T3 cells (31) and bone marrow-derived MSC (32). Choy et al. (31) showed that activation of Smad2/3 pathway by TGFR complex can repress activity of C/EBPs with secondary transcriptional inhibition of PPARγ promoter in 3T3 cells. We found similar TGFβ inhibitory effect on PPARγ expression in fibrocytes and SQ preadipocytes. Furthermore, Zhou et al. (32) demonstrated that reciprocal regulation between TGFβ and Wnt signaling is associated with nuclear accumulation and stability of β-catenin, which reverses the usual PPARγ-associated targeting of β-catenin for proteasome degradation during adipogenesis. Interestingly, TGFβ has previously been shown to promote differentiation of progenitor cells into myofibroblasts (16) , which is associated with enhanced collagen I and α-smooth muscle expression. Additional studies are needed to further define how these defined growth factors and conditions in vitro may be related to the specific microenvironmental niche in vivo that is permissive to enhance fibrocyte adipogenesis and trafficking into adipose tissue.
Analysis of genome-wide expression profiling offered us an attractive tool for studying relationships between gene clusters and molecular pathways leading to the differentiation of fibrocytes toward adipocytes. We found that many of well-studied adipocyte markers were enriched in the differentiation of fibrocytes to adipocytes, including C/EBPα, resistin, lipoprotein lipase, CCL2, and CXCL8. When we generated pathway associations linking known adipogenic regulatory genes based on our microarray results, general expression trends were similar between fibrocyte-derived adipocytes, SQ, and visceral adipocytes. We also performed a universal screen of all differentially expressed genes, from which we were able to segregate specific gene clusters activated during adipogenesis. Certain clusters, such as those involved in lipoprotein metabolism and fatty acid biosynthesis, were globally augmented following differentiation of fibrocytes, as well as both SQ and visceral preadipocytes. This suggests a potential link in physiological roles shared by the three cell types. Conversely, certain gene clusters were differentially regulated only during fibrocyte adipogenesis, such as those involved in cell motility, chemotaxis, or metalloproteinase activity. One conclusion emerging from these data is that the divergence in expression profile may reflect the heterogeneity of our fibrocyte-derived adipocyte population or inherent differences in the genetic regulatory network used by fibrocytes during lineage commitment. Alternatively, although fibrocyte-derived adipocytes display metabolic characteristics of an adipocyte, it may also possess unique functions for motility and chemoattractive activity that might allow the cell to participate in migration and trafficking relevant to a cell in circulation and homing to specific tissue site.
We also wanted to assess whether human fibrocyte-derived adipocytes can form adipose tissue in vivo. We used a Matrigel system, whereby these cells were implanted into SCID mice. Through immunostaining using human specific leptin antibody, we determined that the new adipose tissue was likely derived from human adipocytes and not from maturation of surrounding endogenous preadipocytes. Although the link between adipogenesis and angiogenesis has been well established (33, 34) , the exact origin of the vascular cells in the newly formed fat pad was less clear. They likely originate from out-sprouting of local blood vessels, although recruitment of circulating endothelial progenitors and even direct conversion from fibrocytes are intriguing possibilities.
Finally, previous studies have shown that these progenitor cells express an array of chemokine receptors, including CCR7 and CXCR4. We now demonstrate that after fibrocyte differentiation to adipocytes, there is an increase in expression of CCR2 associated with increased chemotactic response to CCL2. It has been established that levels of certain chemokines, such as CCL2, are up-regulated during obesity (35) (36) (37) . In particular, CCL2 release is higher in obese subjects, associated with increased expression from visceral adipose tissue (38). We hypothesize that under homeostatic conditions, fibrocytes remain at low levels in the peripheral circulation. However, under a different microenvironmental niche related to positive energy balance, fibrocytes may increase in number and traffic to adipose tissue in which levels of CCL2 are elevated. Although beyond the scope of this paper, studies are currently in progress to elucidate mechanisms by which CCR2 + fibrocyte-derived adipocytes are recruited to adipose tissue in response to release of CCL2 and contribute to the formation of adipose tissue.
In summary, our findings demonstrate for the first time that adult fibrocytes are circulating progenitors that can differentiate into adipocytes with expression of key adipogenic markers consistent with other models of adipogenesis. Although future studies are needed to fully elucidate the signaling pathways involved, it is tempting to speculate that fibrocytes may prove to be an attractive therapeutic target in preventing the development of obesity related to Metabolic Syndrome. A) FACS analysis showed significant increase in surface CCR2 expression following adipogenic differentiation as compared with untreated fibrocytes; B) Significant up-regulation of CCR2 mRNA levels was detected following adipogenic induction in fibrocytes; C) Fibrocyte migration was measured in the absence or presence of CCL2. Significant chemotactic activity to CCL2 was detected at both 1 and 3 weeks after adipogenic treatment.
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